Dow Jones futures rose modestly Thursday morning, along with S&P 500 futures and Nasdaq futures, with the S&P 500 eyeing a record high. Snap stock and Tesla continued to climb after big moves Wednesday, while Eli Lilly
) said it'll seek FDA approval for its Alzheimer's drug this year. Accenture
) eyed a breakout on earnings.
A bipartisan group of senators said Wednesday night they've reached the outlines of a infrastructure spending deal with the White House. An agreement could come today.
The stock market rally had a quietly bullish Wednesday, with the Nasdaq holding at record highs while leaders and growth stocks had solid sessions.
Snapchat parent Snap
) ran higher, breaking past resistance into a buy zone. Tesla
) jumped Wednesday, flashing a couple of early buy signals. Both Snap and Tesla stock continued rising in Thursday's premarket.
Accenture reported better-than-expected earnings before the open, with revenue up 20.5%, the best gain in years. The global tech and consulting firm also raised full-year guidance. ACN stock rose 4% before the open, suggesting a move above a 294.60 flat-base buy point. Accenture has been finding support at its 50-day line.